查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1403472

2030 年合成基因组学市场预测：按产品、应用、最终用户和地区进行的全球分析

Synthetic Genomics Market Forecasts to 2030 - Global Analysis By Product (Adapters, DNA Template, Klenow Fragment, Modifying Enzymes, Primers and Other Products), Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球合成基因组市场规模将达到 303 亿美元，预计到 2030 年将达到 787 亿美元，预测期内复合年增长率为 14.6%。

合成生物学是一个快速发展的领域，涉及遗传物质的生产和操作，包含在合成基因组学市场中。这个领域涉及创建、建构和改进用于多种用途的合成 DNA 序列，包括创建基因改造生物、人造细胞和客製化遗传电路。合成基因组学对于医学领域的药物开发、基因治疗和个体化医疗至关重要。在农业领域，它有助于创造具有更好特性的基因改造作物。

根据世界经济论坛 2021 年 9 月发布的资料，由于针对病毒的 mRNA 疫苗的开发，合成生物学的进步在控制流行病方面具有巨大潜力。

加大研发投入

随着合成基因组学的快速发展，需要额外的研发资金来促进创新和新技术。这些投资用于资助 DNA 合成、基因编辑和其他遗传物质操作的尖端方法的探索。此外，公共和私营部门都认识到合成基因组在医疗保健、农业和工业应用中的巨大潜力，因此增加了对研究计画的财政支持。

研发成本高

由于基因工程复杂且需要尖端技术，中小型企业和研究机构被认为很难进入市场。创建先进的基因编辑工具、DNA合成技术和其他重要技术需要大量资金，这阻碍了许多人从事这一领域的工作。然而，公司在合成基因组学领域探索和创新的能力可能会受到大量初始投资和持续研发成本的限制。

合成生物学解决方案的需求不断增长

合成基因组学是合成生物学的一个方面，它正在促进各个领域对创新和适应性生物解决方案不断增长的需求。随着公司和教育机构意识到合成基因组学在创造和修改遗传物质方面具有巨大潜力，对客製化生物系统的需求正在增加。这种需求的应用范围很广，包括工业生物技术、医疗保健、农业等。此外，利用合成基因组学，可以对生物体进行工程改造以执行特定任务，例如为工业过程创造生物基材料、具有改进特性的基因工程作物以及药物治疗。

安全和生物安全问题

由于操纵遗传物质和产生合成生物体的可能性，引起了人们对将合成基因组学用于邪恶目的的担忧。为了减轻这些担忧，政府和监管机构必须制定严格的法律，禁止非法取得基因技术。可能会製造出具有恶意目的的基因改造生物，例如生物武器，因此需要采取有效的安全预防措施。然而，由于这些担忧，合成基因组市场的公司难以管理合规性要求，减缓了监管核准流程并加强了审查。

新冠肺炎 (COVID-19) 影响：

全球健康危机已经证明了尖端基因技术在疫苗开发、诊断和替代疗法方面的重要性。合成基因组学使 mRNA 疫苗的快速发展成为可能，并证明该技术可以快速适应新出现的感染疾病。疫情推迟了研究倡议、扭转了供应链并将资源用于紧急医疗保健需求，间接影响了市场成长轨迹。资金筹措限制和经济不确定性影响了该行业规模较小的参与者。

DNA模板片段预计在预测期内是最大的

由于 DNA 模板对于准确有效地合成遗传物质至关重要，因此它在合成基因组学市场中占据最大份额。 DNA 合成技术的进步，包括自动化 DNA 合成平台和创新方法，现在使研究和生物技术研究人员能够以前所未有的速度和精度设计和製造客製化的 DNA 序列。此外，各种应用（包括基因治疗、药物药物研发和基因改造牲畜的培育）对合成生物解决方案的需求不断增长，也是推动 DNA 模板领域兴起的因素。

预计器官移植产业在预测期内复合年增长率最高。

由于器官移植在解决器官短缺相关挑战方面具有变革性作用，预计该产业在预测期内将出现盈利成长。为了解决与器官排斥和器官稀缺相关的问题，合成基因体学已成为生产具有更高相容性的器官和组织的有效方法。此外，精确基因工程器官的能力提供了为特定患者量身定制移植物、抑制免疫反应并提高移植成功率的潜力。

占比最大的地区：

在预测期内，亚太地区占据了最大的市场份额。这是由于该地区经济的快速工业化和技术进步，以及人们日益认识到合成基因组学在许多领域的革命性潜力。中国、日本、印度等国家正在进行大规模的研发投入，为合成基因体学的发展创造了完美的环境。学术机构、研究机构和生物技术公司积极推动前沿倡议，以促进创新和新应用的创造。

复合年增长率最高的地区：

随着对精准医疗和个人化医疗保健的日益关注，由于医疗保健相关计划的增加，亚太地区正在经历盈利成长。合成基因组学对于这些努力至关重要，因为它能够客製化遗传干预、基因疗法和诊断工具。合成基因组学技术的使用因其解决当地健康问题和提供定製药物疗法的潜力而受到推动。此外，新加坡和中国等国家的政府正在积极支持合成生物学和生物技术领域的努力，投入资源和基础设施来支持这些领域的研究和开发的进步。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球合成基因体学市场：副产品

  • 适配器
  • 脱氧核糖核酸模板
  • 克列诺的碎片
  • 酵素修饰
  • 底漆
  • 其他产品

第六章全球合成基因体学市场：依应用分类

  • 细菌抗药性
  • DNA列印
  • 创新疫苗和治疗方法
  • 营养蛋白质和油
  • 器官移植
  • 其他用途

第七章全球合成基因组学市场：依最终用户分类

  • 学术机构
  • 生技公司
  • 受託研究机构
  • 政府研究所
  • 製药公司
  • 其他最终用户

第八章全球合成基因体学市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第九章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十章 公司简介

  • Biocompare Inc
  • Boster Biological Technology
  • Eurofins Genomics
  • Genewiz
  • GenScript
  • Integrated DNA Technologies Inc
  • Synthetic Genomics Inc
  • Thermo Fisher Scientific Inc
  • Twist Bioscience
Product Code: SMRC24697

According to Stratistics MRC, the Global Synthetic Genomics Market is accounted for $30.3 billion in 2023 and is expected to reach $78.7 billion by 2030 growing at a CAGR of 14.6% during the forecast period. The rapidly growing field of synthetic biology, which involves the production and manipulation of genetic material, is included in the Synthetic Genomics Market. It involves the creation, building, and refinement of synthetic DNA sequences for a variety of applications, including the creation of genetically modified creatures, artificial cells, and tailored genetic circuits. Synthetic genomics is essential to drug development, gene therapy, and customized medicine in the field of medicine. It aids in the creation of genetically engineered crops with enhanced attributes in agriculture.

According to a data published by the World Economic Forum in September 2021, the advancements in the synthetic biology have a vast potential to manage the pandemic for the development of mRNA vaccine against virus.

Market Dynamics:

Driver:

Growing investments in research and development activities

As synthetic genomics develops rapidly, additional funding for research and development is needed to promote innovation and new technologies. These investments fund the examination of cutting-edge methods for DNA synthesis, gene editing, and other genetic material manipulation. Additionally, growing financial support for research initiatives is a result of both the public and private sectors recognizing the enormous potential of synthetic genomes in healthcare, agriculture, and industrial applications.

Restraint:

High costs of research and development

Due to the complexity of genetic engineering and the requirement for cutting-edge technologies, smaller businesses and research institutions consider it difficult to enter the market. Significant money is needed to create advanced gene editing tools, DNA synthesis techniques, and other critical technologies, which prevents numerous individuals from working in this field. However, companies' capacity to explore and innovate in synthetic genomics may be constrained by the significant initial investment and ongoing research and development costs.

Opportunity:

Rising demand for synthetic biology solutions

Synthetic genomics, a fundamental aspect of synthetic biology, contributes to the growing demand for innovative and adaptable biological solutions in a range of sectors. Customized biological systems are becoming more and more in demand as companies and educational institutions realize the enormous promise synthetic genomics has for creating and modifying genetic material. Applications for this demand are wide-ranging and include industrial biotechnology, healthcare, and agriculture. Moreover, with the use of synthetic genomics, biological organisms can be designed to do specific duties, such as creating bio-based materials for industrial processes, genetically modified crops with improved features, and medicinal treatments.

Threat:

Security and biosecurity concerns

Fears regarding the exploitation of synthetic genomics for malevolent terminates are triggered by the manipulation of genetic material and the potential production of synthetic creatures. To mitigate these worries, governments and regulatory agencies must impose stringent laws that prohibit illegal access to genetic technologies. Effective safety precautions are necessary due to the possibility of creating genetically modified organisms with malicious intent, such as bioweapons. However, companies in the synthetic genome market find it difficult to manage compliance requirements as a result of these worries, which also slow down the regulatory approval process and raise scrutiny.

COVID-19 Impact:

The relevance of cutting-edge genetic technologies for vaccine development, diagnostics, and treatment alternatives has been demonstrated by the global health crisis. The rapid development of mRNA vaccinations was made possible by synthetic genomics, demonstrating the technology's capacity to adapt rapidly to new infections. The pandemic managed to indirectly affect the market's growth trajectory by delaying research initiatives, reversing supply chains, and directing resources to urgent healthcare requirements. Funding limitations and economic uncertainty had an impact on the industry's smaller participants.

The DNA template segment is expected to be the largest during the forecast period

Due to its crucial significance in the accurate and effective synthesis of genetic material, the DNA template segment held the largest share in the synthetic genomics market. Researchers and biotechnologists can design and manufacture customized DNA sequences with previously unattainable speed and accuracy because of advancements in DNA synthesis technology, including automated DNA synthesis platforms and innovative approaches. Furthermore, the growing need for synthetic biology solutions for a variety of applications, such as gene therapy, drug discovery, and the generation of genetically modified livestock, is the factor that is causing this rise in the DNA template sector.

The organ transplantation segment is expected to have the highest CAGR during the forecast period

Because organ transplantation has a transformative effect on addressing the challenges associated with organ shortages, the segment is expected to grow profitably during the projected period. To address the issues associated with organ rejection and scarcity, synthetic genomics has emerged as a potentially efficient way of producing organs and tissues with improved compatibility. Additionally, the capacity to precisely modify organs genetically offers the possibility of customizing grafts for particular patients, reducing immunological reactions, and raising transplant success rates.

Region with largest share:

Over the course of the projected period, the Asia Pacific region had the largest share of the market due to the region's economies experiencing rapid industrialization and technological improvement, as well as the increasing awareness of the revolutionary potential of synthetic genomics across numerous sectors. Significant R&D investments have been made by nations like China, Japan, and India, creating an optimal environment for the development of synthetic genomics. Cutting-edge initiatives are being actively promoted by academic institutions, research organizations, and biotech corporations, which promote innovation and the creation of new applications.

Region with highest CAGR:

With an increasing focus on precision medicine and tailored healthcare, the Asia-Pacific area is experiencing profitable growth as a result of an increase in healthcare-related projects. Because it renders it feasible to customize genetic interventions, gene therapies, and diagnostic tools, synthetic genomics is essential to these initiatives. The use of synthetic genomics technology is being propelled by its potential to address regional health concerns and offer customized medicinal therapies. Moreover, governments in nations like Singapore and China are actively supporting efforts in the domains of synthetic biology and biotechnology, offering resources and infrastructure to support the advancement of these fields' research and development.

Key players in the market:

Some of the key players in Synthetic Genomics market include Biocompare Inc , Boster Biological Technology, Eurofins Genomics, Genewiz, GenScript, Integrated DNA Technologies Inc, Synthetic Genomics Inc, Thermo Fisher Scientific Inc and Twist Bioscience .

Key Developments:

In October 2023, Global genomics solutions provider Integrated DNA Technologies (IDT), an operating company in the Life Sciences segment of Danaher Corporation announced the completion of its new Therapeutic Oligonucleotide Manufacturing facility in Coralville, Iowa. The milestone marks a significant achievement in the company's 35-year-history-its entrance into the therapeutics space-and enables IDT to manufacture products for research use through to current good manufacturing practice (cGMP) grade cell and gene therapy reagents to provide researchers with a single partner that can help them rapidly transition from the lab to therapeutic development.

In February 2023, Ultima Genomics, Inc., a developer of a revolutionary new ultra-high throughput sequencing architecture, announced a strategic collaboration with global genomics solutions provider Integrated DNA Technologies (IDT) to enable key next generation sequencing (NGS) applications on Ultima platforms.

In February 2023, Twist Bioscience announces technology early access of enhanced whole genome sequencing solution at AGBT. eWGS is a novel solution that enables researchers to obtain simultaneous low-pass whole genome data together with deep coverage of selected regions, in a high-throughput and cost-effective workflow.

Products Covered:

  • Adapters
  • DNA Template
  • Klenow Fragment
  • Modifying Enzymes
  • Primers
  • Other Products

Applications Covered:

  • Bacterial Resistance
  • DNA Printing
  • Innovative Vaccines & Therapeutics
  • Nutritional Proteins & Oils
  • Organ Transplantation
  • Other Applications

End Users Covered:

  • Academic Institutions
  • Biotechnology Companies
  • Contract Research Organizations
  • Government Laboratories
  • Pharmaceutical companies
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Synthetic Genomics Market, By Product

  • 5.1 Introduction
  • 5.2 Adapters
  • 5.3 DNA Template
  • 5.4 Klenow Fragment
  • 5.5 Modifying Enzymes
  • 5.6 Primers
  • 5.7 Other Products

6 Global Synthetic Genomics Market, By Application

  • 6.1 Introduction
  • 6.2 Bacterial Resistance
  • 6.3 DNA Printing
  • 6.4 Innovative Vaccines & Therapeutics
  • 6.5 Nutritional Proteins & Oils
  • 6.6 Organ Transplantation
  • 6.7 Other Applications

7 Global Synthetic Genomics Market, By End User

  • 7.1 Introduction
  • 7.2 Academic Institutions
  • 7.3 Biotechnology Companies
  • 7.4 Contract Research Organizations
  • 7.5 Government Laboratories
  • 7.6 Pharmaceutical companies
  • 7.7 Other End Users

8 Global Synthetic Genomics Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Biocompare Inc
  • 10.2 Boster Biological Technology
  • 10.3 Eurofins Genomics
  • 10.4 Genewiz
  • 10.5 GenScript
  • 10.6 Integrated DNA Technologies Inc
  • 10.7 Synthetic Genomics Inc
  • 10.8 Thermo Fisher Scientific Inc
  • 10.9 Twist Bioscience

List of Tables

  • Table 1 Global Synthetic Genomics Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Synthetic Genomics Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Synthetic Genomics Market Outlook, By Adapters (2021-2030) ($MN)
  • Table 4 Global Synthetic Genomics Market Outlook, By DNA Template (2021-2030) ($MN)
  • Table 5 Global Synthetic Genomics Market Outlook, By Klenow Fragment (2021-2030) ($MN)
  • Table 6 Global Synthetic Genomics Market Outlook, By Modifying Enzymes (2021-2030) ($MN)
  • Table 7 Global Synthetic Genomics Market Outlook, By Primers (2021-2030) ($MN)
  • Table 8 Global Synthetic Genomics Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 9 Global Synthetic Genomics Market Outlook, By Application (2021-2030) ($MN)
  • Table 10 Global Synthetic Genomics Market Outlook, By Bacterial Resistance (2021-2030) ($MN)
  • Table 11 Global Synthetic Genomics Market Outlook, By DNA Printing (2021-2030) ($MN)
  • Table 12 Global Synthetic Genomics Market Outlook, By Innovative Vaccines & Therapeutics (2021-2030) ($MN)
  • Table 13 Global Synthetic Genomics Market Outlook, By Nutritional Proteins & Oils (2021-2030) ($MN)
  • Table 14 Global Synthetic Genomics Market Outlook, By Organ Transplantation (2021-2030) ($MN)
  • Table 15 Global Synthetic Genomics Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 16 Global Synthetic Genomics Market Outlook, By End User (2021-2030) ($MN)
  • Table 17 Global Synthetic Genomics Market Outlook, By Academic Institutions (2021-2030) ($MN)
  • Table 18 Global Synthetic Genomics Market Outlook, By Biotechnology Companies (2021-2030) ($MN)
  • Table 19 Global Synthetic Genomics Market Outlook, By Contract Research Organizations (2021-2030) ($MN)
  • Table 20 Global Synthetic Genomics Market Outlook, By Government Laboratories (2021-2030) ($MN)
  • Table 21 Global Synthetic Genomics Market Outlook, By Pharmaceutical companies (2021-2030) ($MN)
  • Table 22 Global Synthetic Genomics Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 23 North America Synthetic Genomics Market Outlook, By Country (2021-2030) ($MN)
  • Table 24 North America Synthetic Genomics Market Outlook, By Product (2021-2030) ($MN)
  • Table 25 North America Synthetic Genomics Market Outlook, By Adapters (2021-2030) ($MN)
  • Table 26 North America Synthetic Genomics Market Outlook, By DNA Template (2021-2030) ($MN)
  • Table 27 North America Synthetic Genomics Market Outlook, By Klenow Fragment (2021-2030) ($MN)
  • Table 28 North America Synthetic Genomics Market Outlook, By Modifying Enzymes (2021-2030) ($MN)
  • Table 29 North America Synthetic Genomics Market Outlook, By Primers (2021-2030) ($MN)
  • Table 30 North America Synthetic Genomics Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 31 North America Synthetic Genomics Market Outlook, By Application (2021-2030) ($MN)
  • Table 32 North America Synthetic Genomics Market Outlook, By Bacterial Resistance (2021-2030) ($MN)
  • Table 33 North America Synthetic Genomics Market Outlook, By DNA Printing (2021-2030) ($MN)
  • Table 34 North America Synthetic Genomics Market Outlook, By Innovative Vaccines & Therapeutics (2021-2030) ($MN)
  • Table 35 North America Synthetic Genomics Market Outlook, By Nutritional Proteins & Oils (2021-2030) ($MN)
  • Table 36 North America Synthetic Genomics Market Outlook, By Organ Transplantation (2021-2030) ($MN)
  • Table 37 North America Synthetic Genomics Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 38 North America Synthetic Genomics Market Outlook, By End User (2021-2030) ($MN)
  • Table 39 North America Synthetic Genomics Market Outlook, By Academic Institutions (2021-2030) ($MN)
  • Table 40 North America Synthetic Genomics Market Outlook, By Biotechnology Companies (2021-2030) ($MN)
  • Table 41 North America Synthetic Genomics Market Outlook, By Contract Research Organizations (2021-2030) ($MN)
  • Table 42 North America Synthetic Genomics Market Outlook, By Government Laboratories (2021-2030) ($MN)
  • Table 43 North America Synthetic Genomics Market Outlook, By Pharmaceutical companies (2021-2030) ($MN)
  • Table 44 North America Synthetic Genomics Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 45 Europe Synthetic Genomics Market Outlook, By Country (2021-2030) ($MN)
  • Table 46 Europe Synthetic Genomics Market Outlook, By Product (2021-2030) ($MN)
  • Table 47 Europe Synthetic Genomics Market Outlook, By Adapters (2021-2030) ($MN)
  • Table 48 Europe Synthetic Genomics Market Outlook, By DNA Template (2021-2030) ($MN)
  • Table 49 Europe Synthetic Genomics Market Outlook, By Klenow Fragment (2021-2030) ($MN)
  • Table 50 Europe Synthetic Genomics Market Outlook, By Modifying Enzymes (2021-2030) ($MN)
  • Table 51 Europe Synthetic Genomics Market Outlook, By Primers (2021-2030) ($MN)
  • Table 52 Europe Synthetic Genomics Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 53 Europe Synthetic Genomics Market Outlook, By Application (2021-2030) ($MN)
  • Table 54 Europe Synthetic Genomics Market Outlook, By Bacterial Resistance (2021-2030) ($MN)
  • Table 55 Europe Synthetic Genomics Market Outlook, By DNA Printing (2021-2030) ($MN)
  • Table 56 Europe Synthetic Genomics Market Outlook, By Innovative Vaccines & Therapeutics (2021-2030) ($MN)
  • Table 57 Europe Synthetic Genomics Market Outlook, By Nutritional Proteins & Oils (2021-2030) ($MN)
  • Table 58 Europe Synthetic Genomics Market Outlook, By Organ Transplantation (2021-2030) ($MN)
  • Table 59 Europe Synthetic Genomics Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 60 Europe Synthetic Genomics Market Outlook, By End User (2021-2030) ($MN)
  • Table 61 Europe Synthetic Genomics Market Outlook, By Academic Institutions (2021-2030) ($MN)
  • Table 62 Europe Synthetic Genomics Market Outlook, By Biotechnology Companies (2021-2030) ($MN)
  • Table 63 Europe Synthetic Genomics Market Outlook, By Contract Research Organizations (2021-2030) ($MN)
  • Table 64 Europe Synthetic Genomics Market Outlook, By Government Laboratories (2021-2030) ($MN)
  • Table 65 Europe Synthetic Genomics Market Outlook, By Pharmaceutical companies (2021-2030) ($MN)
  • Table 66 Europe Synthetic Genomics Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 67 Asia Pacific Synthetic Genomics Market Outlook, By Country (2021-2030) ($MN)
  • Table 68 Asia Pacific Synthetic Genomics Market Outlook, By Product (2021-2030) ($MN)
  • Table 69 Asia Pacific Synthetic Genomics Market Outlook, By Adapters (2021-2030) ($MN)
  • Table 70 Asia Pacific Synthetic Genomics Market Outlook, By DNA Template (2021-2030) ($MN)
  • Table 71 Asia Pacific Synthetic Genomics Market Outlook, By Klenow Fragment (2021-2030) ($MN)
  • Table 72 Asia Pacific Synthetic Genomics Market Outlook, By Modifying Enzymes (2021-2030) ($MN)
  • Table 73 Asia Pacific Synthetic Genomics Market Outlook, By Primers (2021-2030) ($MN)
  • Table 74 Asia Pacific Synthetic Genomics Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 75 Asia Pacific Synthetic Genomics Market Outlook, By Application (2021-2030) ($MN)
  • Table 76 Asia Pacific Synthetic Genomics Market Outlook, By Bacterial Resistance (2021-2030) ($MN)
  • Table 77 Asia Pacific Synthetic Genomics Market Outlook, By DNA Printing (2021-2030) ($MN)
  • Table 78 Asia Pacific Synthetic Genomics Market Outlook, By Innovative Vaccines & Therapeutics (2021-2030) ($MN)
  • Table 79 Asia Pacific Synthetic Genomics Market Outlook, By Nutritional Proteins & Oils (2021-2030) ($MN)
  • Table 80 Asia Pacific Synthetic Genomics Market Outlook, By Organ Transplantation (2021-2030) ($MN)
  • Table 81 Asia Pacific Synthetic Genomics Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 82 Asia Pacific Synthetic Genomics Market Outlook, By End User (2021-2030) ($MN)
  • Table 83 Asia Pacific Synthetic Genomics Market Outlook, By Academic Institutions (2021-2030) ($MN)
  • Table 84 Asia Pacific Synthetic Genomics Market Outlook, By Biotechnology Companies (2021-2030) ($MN)
  • Table 85 Asia Pacific Synthetic Genomics Market Outlook, By Contract Research Organizations (2021-2030) ($MN)
  • Table 86 Asia Pacific Synthetic Genomics Market Outlook, By Government Laboratories (2021-2030) ($MN)
  • Table 87 Asia Pacific Synthetic Genomics Market Outlook, By Pharmaceutical companies (2021-2030) ($MN)
  • Table 88 Asia Pacific Synthetic Genomics Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 89 South America Synthetic Genomics Market Outlook, By Country (2021-2030) ($MN)
  • Table 90 South America Synthetic Genomics Market Outlook, By Product (2021-2030) ($MN)
  • Table 91 South America Synthetic Genomics Market Outlook, By Adapters (2021-2030) ($MN)
  • Table 92 South America Synthetic Genomics Market Outlook, By DNA Template (2021-2030) ($MN)
  • Table 93 South America Synthetic Genomics Market Outlook, By Klenow Fragment (2021-2030) ($MN)
  • Table 94 South America Synthetic Genomics Market Outlook, By Modifying Enzymes (2021-2030) ($MN)
  • Table 95 South America Synthetic Genomics Market Outlook, By Primers (2021-2030) ($MN)
  • Table 96 South America Synthetic Genomics Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 97 South America Synthetic Genomics Market Outlook, By Application (2021-2030) ($MN)
  • Table 98 South America Synthetic Genomics Market Outlook, By Bacterial Resistance (2021-2030) ($MN)
  • Table 99 South America Synthetic Genomics Market Outlook, By DNA Printing (2021-2030) ($MN)
  • Table 100 South America Synthetic Genomics Market Outlook, By Innovative Vaccines & Therapeutics (2021-2030) ($MN)
  • Table 101 South America Synthetic Genomics Market Outlook, By Nutritional Proteins & Oils (2021-2030) ($MN)
  • Table 102 South America Synthetic Genomics Market Outlook, By Organ Transplantation (2021-2030) ($MN)
  • Table 103 South America Synthetic Genomics Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 104 South America Synthetic Genomics Market Outlook, By End User (2021-2030) ($MN)
  • Table 105 South America Synthetic Genomics Market Outlook, By Academic Institutions (2021-2030) ($MN)
  • Table 106 South America Synthetic Genomics Market Outlook, By Biotechnology Companies (2021-2030) ($MN)
  • Table 107 South America Synthetic Genomics Market Outlook, By Contract Research Organizations (2021-2030) ($MN)
  • Table 108 South America Synthetic Genomics Market Outlook, By Government Laboratories (2021-2030) ($MN)
  • Table 109 South America Synthetic Genomics Market Outlook, By Pharmaceutical companies (2021-2030) ($MN)
  • Table 110 South America Synthetic Genomics Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 111 Middle East & Africa Synthetic Genomics Market Outlook, By Country (2021-2030) ($MN)
  • Table 112 Middle East & Africa Synthetic Genomics Market Outlook, By Product (2021-2030) ($MN)
  • Table 113 Middle East & Africa Synthetic Genomics Market Outlook, By Adapters (2021-2030) ($MN)
  • Table 114 Middle East & Africa Synthetic Genomics Market Outlook, By DNA Template (2021-2030) ($MN)
  • Table 115 Middle East & Africa Synthetic Genomics Market Outlook, By Klenow Fragment (2021-2030) ($MN)
  • Table 116 Middle East & Africa Synthetic Genomics Market Outlook, By Modifying Enzymes (2021-2030) ($MN)
  • Table 117 Middle East & Africa Synthetic Genomics Market Outlook, By Primers (2021-2030) ($MN)
  • Table 118 Middle East & Africa Synthetic Genomics Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 119 Middle East & Africa Synthetic Genomics Market Outlook, By Application (2021-2030) ($MN)
  • Table 120 Middle East & Africa Synthetic Genomics Market Outlook, By Bacterial Resistance (2021-2030) ($MN)
  • Table 121 Middle East & Africa Synthetic Genomics Market Outlook, By DNA Printing (2021-2030) ($MN)
  • Table 122 Middle East & Africa Synthetic Genomics Market Outlook, By Innovative Vaccines & Therapeutics (2021-2030) ($MN)
  • Table 123 Middle East & Africa Synthetic Genomics Market Outlook, By Nutritional Proteins & Oils (2021-2030) ($MN)
  • Table 124 Middle East & Africa Synthetic Genomics Market Outlook, By Organ Transplantation (2021-2030) ($MN)
  • Table 125 Middle East & Africa Synthetic Genomics Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 126 Middle East & Africa Synthetic Genomics Market Outlook, By End User (2021-2030) ($MN)
  • Table 127 Middle East & Africa Synthetic Genomics Market Outlook, By Academic Institutions (2021-2030) ($MN)
  • Table 128 Middle East & Africa Synthetic Genomics Market Outlook, By Biotechnology Companies (2021-2030) ($MN)
  • Table 129 Middle East & Africa Synthetic Genomics Market Outlook, By Contract Research Organizations (2021-2030) ($MN)
  • Table 130 Middle East & Africa Synthetic Genomics Market Outlook, By Government Laboratories (2021-2030) ($MN)
  • Table 131 Middle East & Africa Synthetic Genomics Market Outlook, By Pharmaceutical companies (2021-2030) ($MN)
  • Table 132 Middle East & Africa Synthetic Genomics Market Outlook, By Other End Users (2021-2030) ($MN)